Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
54
datasets available to search
ShareScore release 0.9.0
Dataset results
54 results for “2992”
Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01090011. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Trento 1936 - Building 2992
<u>Coordinates</u>: N/A <br><u>Length</u>: 24.39 m<br><u>Width</u>: 8.81 m<br><u>Height</u>: 18.0 m<br><u>Points</u>: 18 <br><u>Vertices</u>: 96 <br><u>Primitives</u>: 32 <br><br><u>Main Files:</u><br><table><tbody><tr><th>Filename</th><th>.glb</th><th>.xml</th><th>.obj</th></tr><tr><td><a href="https://zenodo.org/api/records/12696155/files/building_2992.obj/content">building_2992.obj</a></td><td></td><td></td><td><a href="https://zenodo.org/api/records/12696155/files/building_2992.obj/content">Link</a></td></tr><tr><td><a href="https://zenodo.org/api/records/12696155/files/building_2992.glb/content">building_2992.glb</a></td><td><a href="https://zenodo.org/api/records/12696155/files/building_2992.glb/content">Link</a></td><td></td><td></td></tr><tr><td><a href="https://zenodo.org/api/records/12696155/files/11577300_metsmods.xml/content">11577300_metsmods.xml</a></td><td></td><td><a href="https://zenodo.org/api/records/12696155/files/11577300_metsmods.xml/content">Link</a></td><td></td></tr><tr><td><a href="https://zenodo.org/api/records/12696155/files/11577300_edm.xml/content">11577300_edm.xml</a></td><td></td><td><a href="https://zenodo.org/api/records/12696155/files/11577300_edm.xml/content">Link</a></td><td></td></tr></tbody></table><br><br><u>Thumbnails:</u><br><table><tbody><tr><th>Perspective</th><th>1000x1000</th><th>512x512</th><th>256x256</th><th>128x128</th></tr><tr><td>Perspective 1</td><td><a href="https://zenodo.org/api/records/12696155/files/building_2992_perspective_1.png/content">Link</a></td><td><a href="https://zenodo.org/api/records/12696155/files/building_2992_perspective_1_512x512.png/content">Link</a></td><td><a href="https://zenodo.org/api/records/12696155/files/building_2992_perspective_1_256x256.png/content">Link</a></td><td><a href="https://zenodo.org/api/records/12696155/files/building_2992_perspective_1_128x128.png/content">Link</a></td></tr><tr><td>Perspective 2</td><td><a href="https://zenodo.org/api/records/12696155/files/building_2992_perspective_2.png/content">Link</a></td><td><a href="https://zenodo.org/api/records/12696155/files/building_2992_perspective_2_512x512.png/content">Link</a></td><td><a href="https://zenodo.org/api/records/12696155/files/building_2992_perspective_2_256x256.png/content">Link</a></td><td><a href="https://zenodo.org/api/records/12696155/files/building_2992_perspective_2_128x128.png/content">Link</a></td></tr><tr><td>Perspective 3</td><td><a href="https://zenodo.org/api/records/12696155/files/building_2992_perspective_3.png/content">Link</a></td><td><a href="https://zenodo.org/api/records/12696155/files/building_2992_perspective_3_512x512.png/content">Link</a></td><td><a href="https://zenodo.org/api/records/12696155/files/building_2992_perspective_3_256x256.png/content">Link</a></td><td><a href="https://zenodo.org/api/records/12696155/files/building_2992_perspective_3_128x128.png/content">Link</a></td></tr><tr><td>Perspective 4</td><td><a href="https://zenodo.org/api/records/12696155/files/building_2992_perspective_4.png/content">Link</a></td><td><a href="https://zenodo.org/api/records/12696155/files/building_2992_perspective_4_512x512.png/content">Link</a></td><td><a href="https://zenodo.org/api/records/12696155/files/building_2992_perspective_4_256x256.png/content">Link</a></td><td><a href="https://zenodo.org/api/records/12696155/files/building_2992_perspective_4_128x128.png/content">Link</a></td></tr><tr><td>Perspective Top</td><td><a href="https://zenodo.org/api/records/12696155/files/building_2992_perspective_top.png/content">Link</a></td><td><a href="https://zenodo.org/api/records/12696155/files/building_2992_perspective_top_512x512.png/content">Link</a></td><td><a href="https://zenodo.org/api/records/12696155/files/building_2992_perspective_top_256x256.png/content">Link</a></td><td><a href="https://zenodo.org/api/records/12696155/files/building_2992_perspective_top_128x128.png/content">Link</a></td></tr></tbody></table><br><br><br><u>Changelog</u>: <br> - v<a href="https://doi.org/10.5281/zenodo.12548167">0.0.2</a>: Thumbnails added, Description updated with Link Tables.<br> - v<a href="https://doi.org/10.5281/zenodo.12696155">0.0.3</a>: Added XMLs for Europeana Data Model (EDM) and MetsMods.<br>
BIBW 2992 and Letrozole in Hormonoresistant Metastatic Breast Cancer
ClinicalTrials.gov study NCT00708214. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT01542437. IPD Sharing: NO. Countries: 1. Publications: 29.
BIBW 2992 (Afatinib) for the Treatment of Patients With HER2-positive, Hormone-refractory Prostate Cancer
ClinicalTrials.gov study NCT01320280. IPD Sharing: Not stated. Countries: 1. Publications: 2.
IO Islamic 2992. Muntakhab-i-Lubâb, History of the Tîmûrides in India (Selections)
<p>IO Islamic 2992. Muntakhab-i-Lubâb, History of the Tîmûrides in India (Selections)</p>
6 Weeks Treatment of Locally Advanced Breast Cancer With BIBW 2992 (Afatinib) or Lapatinib or Trastuzumab
ClinicalTrials.gov study NCT00826267. IPD Sharing: Not stated. Countries: 4. Publications: 0.
A Study of BIBW 2992 (Afatinib) in Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT01152437. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT01999985. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma
ClinicalTrials.gov study NCT00727506. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Multi-centre 3-arm Randomised Phase II Trial of BIBF 1120 Versus BIBW 2992 Versus Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Hormone-resistant Prostate Cancer
ClinicalTrials.gov study NCT00706628. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Afatinib (BIBW 2992) QTcF Trial in Patients With Relapsed or Refractory Solid Tumours
ClinicalTrials.gov study NCT00875433. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Determine the Maximum Tolerated Dose of BIBW 2992 (Afatinib) When Combined With Cisplatin/Paclitaxel or Cisplatin/5-FU in Patients With Advanced Solid Tumours
ClinicalTrials.gov study NCT00716417. IPD Sharing: YES. Countries: 1. Publications: 0.
BIBW 2992 (Afatinib) and Vinorelbine in Japanese Patients With Advanced Solid Tumours
ClinicalTrials.gov study NCT01214616. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Trial of BIBW 2992 in Patients With HER2-positive Metastatic Breast Cancer After Failure of Trastuzumab Therapy
ClinicalTrials.gov study NCT00431067. IPD Sharing: Not stated. Countries: 2. Publications: 0.
LUX-Head & Neck 4: Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy
ClinicalTrials.gov study NCT02131155. IPD Sharing: Not stated. Countries: 4. Publications: 0.
An Open Label Phase II Trial of BIBW 2992 in Patients With HER2-negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT00425854. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Phase II Trial of BIBW 2992 (Afatinib) in Genetically Pre-screened Cancers With EGFR and/or HER2 Gene Amplification.
ClinicalTrials.gov study NCT00748709. IPD Sharing: NO. Countries: 2. Publications: 0.
NN from Colombia collected by F. Moreno y C. Carvajal #2992
<p><strong>File Name</strong>: <span>TOLI-22611-PER-01-X3-4.jpg</span></p> <p><strong>CÓDIGO FOTO</strong>: <span>TOLI-22611-PER-01-X3-4-</span></p> <p><strong>Fotografía</strong>: <span>SI</span></p> <p><strong>Nº TOLI</strong>: <span>TOLI-22611</span></p> <p><strong>PARCELA</strong>: <span>PER-01</span></p> <p><strong>CÓDIGO</strong>: <span>X3-4</span></p> <p><strong>Nº COLECTA</strong>: <span>2992</span></p> <p><strong>NUEVOS COLECTORES</strong>: <span>Esteban Álvarez Dávila</span></p> <p><strong>COLECTORES</strong>: <span>F. Moreno y C. Carvajal</span></p> <p><strong>Nº MUESTRAS MONTADAS</strong>: <span>1</span></p> <p><strong>Homologación</strong>: <span>No homologado</span></p> <p><strong>Nueva fecha del evento </strong>: <span>20/12/2018.</span></p> <p><strong>Fecha del evento</strong>: <span>01/09/2012.</span></p> <p><strong>Proyecto </strong>: <span>Recursos Botánicos Disponibles en Línea (BRAVO) para la flora Colombiana</span></p> <p><strong>Hábitat</strong>: <span>Bosque húmedo tropical (bh-T)</span></p> <p><strong>Comentario del evento</strong>: <span>Bosque de tierra firme, dosel abierto, de 25-30 m, emergentes de 35 m, estrato medio de 15 m, sotobosque denso con alta regeneración natural, presencia de palmas como Lepidocaryum tenue, Oenocarpus bataua, Geonoma sp., capa de hojarazca de 15 cm, abundante materia orgánica. Pendientes pronunciadas. Poca intervención antrópica.</span></p> <p><strong>Continente</strong>: <span>SA</span></p> <p><strong>Pais</strong>: <span>Colombia</span></p> <p><strong>Estado/Provincia</strong>: <span>Amazonas</span></p> <p><strong>Municipio</strong>: <span>Puerto Santander</span></p> <p><strong>Localidad</strong>: <span>Resguardo indígena Nonuya de Villazul.</span></p> <p><strong>Elevación minima en metros</strong>: <span>250</span></p> <p><strong>Elevación maxima en metros</strong>: <span>400</span></p> <p><strong>Latitud</strong>: <span>-0.654</span></p> <p><strong>Longitud original</strong>: <span>-72.072</span></p> <p><strong>datum geodésico</strong>: <span>WGS 84</span></p> <p><strong>Latitud decimal</strong>: <span>-0.654</span></p> <p><strong>Longitud decimal</strong>: <span>-72.072</span></p> <p><strong>Nombre cientifico</strong>: <span>NN</span></p> <p><strong>Reino</strong>: <span>Plantae</span></p> <p><strong>Filo</strong>: <span>Magnoliophyta</span></p> <p><strong>Clase</strong>: <span>Equisetopsida</span></p> <p><strong>Orden</strong>: <span>Ericales</span></p> <p><strong>Familia nueva</strong>: <span>Lecythidaceae</span></p> <p><strong>Género nuevo</strong>: <span>NN</span></p> <p><strong></strong>: <span>Lecythidaceae</span></p> <p><strong>genero herbario</strong>: <span>NN</span></p> <p><strong>Especie de herbario para TNRS</strong>: <span>NN </span></p> <p><strong>Especie corregida herbario y desde TNRS</strong>: <span>Indet indet</span></p> <p><strong>Familia corregida desde TNRS</strong>: <span>Lecythidaceae</span></p> <p><strong></strong>: <span>1740</span></p>
Phase I Open Label Trial to Assess Safety of BIBW 2992 (Afatinib) in Combination With Herceptin® in Patients With HER2-positive Advanced Breast Cancer.
ClinicalTrials.gov study NCT00950742. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.